Sage Journals: Discover world-class research

Free access

Research article

First published 2016-7

Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors

Jacob Beyer, Toby Trujillo, Sheila Fisher [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2022-12

Evaluation of Anti-Xa Apixaban and Rivaroxaban Levels With Respect to Known Doses in Relation to Major Bleeding Events

Steffany N. Nguyen, Melanie C. Ruegger, Eric Salazar [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2022-11

Observed Apixaban Anti-Xa Levels in Obese Patients

Weston Harkness, Olivia Pipitone, Jacqueline Joss [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2004-4

Variability of Plasma Anti-Xa Activities with Different Lots of Enoxaparin

Robert C Gosselin, Jeffery H King, Kim A Janatpour [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2022-12

Comparison of Managing Factor Xa Inhibitor to Unfractionated Heparin Transitions by aPTT Versus a Treatment Guideline Utilizing Heparin Anti-Xa Levels

Scott J. Dingus, Alex R. Smith, William E. Dager [...]

Annals of Pharmacotherapy

Free access

Research article

First published 2016-7

Evaluation of Factor Xa-Specific Chromogenic Substrate Assays and the Determination of Pharmacokinetics of Fondaparinux

Maiko Yuri, Yoko Tabe, Koji Tsuchiya [...]

Clinical and Applied Thrombosis/Hemostasis

Free access

Research article

First published 2002-10

Effects of a Synthetic Factor Xa Inhibitor (JTV-803) on Various Laboratory Tests

Mahmut Tobu, Omer Iqbal, Debra A. Hoppensteadt [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 2008-4

Anti-Xa Stability of Diluted Dalteparin for Pediatric Use

Neil A Goldenberg, Linda Jacobson, Hannah Hathaway [...]

Annals of Pharmacotherapy

Retricted access

Research article

First published 2025-6

Utility of Anti-Xa Levels in Lung Transplant Recipients on Apixaban

Jules Fuentebella, Erwin H. Lam, Rhiannon Garcia [...]

Progress in Transplantation

Open access

Research article

First published 2025

Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients

Kaitlin Blotske, Toral Patel, Toby Trujillo [...]

Clinical and Applied Thrombosis/Hemostasis

Search results